Sarepta Therapeutics Inc. cmn shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Sarepta Therapeutics Inc. cmn shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Sarepta Therapeutics Inc. cmn
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics Inc. cmn held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics Inc. cmn by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $7.2M | 58k | 124.89 |
| 2024-06-30 | $32k | 200 | 158.00 |
| 2024-03-31 | $6.6M | 51k | 129.46 |
| 2023-12-31 | $61M | 633k | 96.43 |
| 2023-09-30 | $80M | 662k | 121.22 |
| 2023-06-30 | $893k | 7.8k | 114.52 |
| 2023-03-31 | $52M | 374k | 137.83 |
| 2022-12-31 | $36M | 278k | 129.58 |
| 2022-03-31 | $3.9M | 50k | 78.12 |
| 2021-12-31 | $36M | 404k | 90.05 |
| 2020-12-31 | $5.1M | 30k | 170.50 |
| 2020-09-30 | $1.8M | 13k | 141.28 |
| 2019-12-31 | $19M | 144k | 129.04 |
| 2019-09-30 | $5.6M | 75k | 75.31 |
| 2019-06-30 | $48M | 370k | 129.76 |
| 2019-03-31 | $26M | 219k | 119.19 |
| 2018-12-31 | $2.9M | 27k | 109.15 |
| 2018-09-30 | $7.1M | 44k | 161.50 |
| 2018-06-30 | $5.9M | 45k | 132.18 |
| 2017-12-31 | $4.7M | 85k | 55.64 |
| 2016-12-31 | $549k | 20k | 27.45 |
Top funds holding Sarepta Therapeutics Inc. cmn
View all funds holding Sarepta Therapeutics Inc. cmn